|
|
||||||||
LETTERS TO THE EDITOR |
Department of Dermatology Brigham and Womens Hospital and Harvard Skin Disease Research Center Boston, MA 02115
We and others have access only to commercially available CCR8 Abs, one of which we used in our recently published studies (1). The letter authors apparently did not see reactivity using this Ab and have generated a polyclonal Ab that they believe is superior. Certainly, we agree that Ab staining is only as good as the Ab used. Polyclonal Abs can have the disadvantage of decreased specificity; for example, polyclonal Abs to CCR8 may also react with CCR5 or other chemokine receptors. Additional specificity controls, beyond the peptide immunogen blocking control reported, should be performed before we can verify that the authors polyclonal Ab is superior. However, it should be noted that both the letter authors and we agree that
50% of skin resident T cells express CCR8 (2). In their original article, the authors found CCR8 expression on 46% of CD4 T cells and 61% of CD8 T cells. In the current letter, the percentage of positive cells is significantly higher, a variance from the previously published data that is not explained. Although the intensity of staining we report is lower, we believe that it is real. Our negative control was an isotype-matched Ab used at the same concentration as the CCR8 Ab. Gates for positive staining were based on this control, with 99% of isotype control-stained cells gated in the negative. Thus, we are comfortable that our CCR8 staining is not an artifact. Indeed, the fact that both our groups found similar expression of CCR8 on skin resident T cells should be considered independent confirmation of this observation, rather than a bone of contention. Of course, if we were provided with this groups CCR8 polyclonal Ab, we could directly replicate their findings.
In contrast, we do take serious issue with the contention that skin T cells resident in normal skin do not express CCR4. We have clear, convincing, and abundant data that the vast majority of skin T cells isolated freshly from skinwhether using EDTA treatment, isolated freshly from skin using collagenase treatment, or isolated from skin using explant culturesexpress high levels of CCR4 (Fig. 1a in Ref. 1). Moreover, we find high expression of CCR4 on virtually all T cells isolated from both sun-exposed (face) and sun-protected skin (breast and abdomen). The authors provide some data above in histogram form showing that collagenase treatment does not affect CCR4 levels. However, dot plots showing CCR8 staining vs CCR4 staining would be much more convincing. We have now tested upward of 30 normal skin donors and have found high expression of CCR4 on T cells from all donors. To settle this issue, we stained frozen sections of normal skin for CD3 and CCR4. Virtually all CD3+ T cells found in normal skin costained for CCR4 (Fig. 1), confirming that T cells in normal skin do express this homing receptor. Using frozen sections, we have likewise confirmed our finding regarding the percentage of CD4 vs CD8 T cells in normal skin and the expression of CLA and CCR6 by T cells resident in normal skin. These data are not shown but can be provided upon request.
|
Lastly, we would stress the point that a homing receptor present on only 50% of skin resident T cells, according to the authors own data, is unlikely to be the major addressin guiding T cells into skin under conditions of normal immunosurveillance. In contrast, CLA and CCR4 are present on the vast majority of T cells from normal skin regardless of the method of T cell isolation, a result we have confirmed by staining frozen sections of normal skin. Moreover, the ligands for CLA and CCR4, E-selectin and thymus and activation-regulated chemokine, are expressed at low but detectable levels in resting cutaneous endothelium (3). This suggests that homing to normal skin uses the same receptors as trafficking to inflamed skin, and thus, it is our belief that homeostatic trafficking to skin relies on quantitative, not qualitative, differences in vascular homing receptor expression. While we do not mean to minimize a potential contributory role for CCR8 in skin homing, we think that the evidence is overwhelming that CLA and CCR4 are both better candidates for homing receptors that support migration of T cells into normal skin. We thank the letter authors for their comments but are confident that our results will stand the test of time.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |